Effect of various potential inhibitors, activators and inducers on the N-oxidation of isomeric aromatic diazines in vitro using rabbit liver microsomal preparations

References

• ANDERS, M. W., and MAXXERIXG, G. J., 1966, Inhibition of drug metabolism. I, Kinetics of the inhibition of 4V-demethylation of ethylmorphine by 2-diethylaminoethy1-2,2-diphenylvalerate HC1(SKF 525-A) and related compounds. Molecular Pharmacology, 2, 319–327.
   PubMed Web of Science ®Google Scholar
• ALTENTAS, T. G., and GoRROn, J. W., 1994, The in vitro oxidation of isomeric aromatic diazine to mono-iV-oxides. Pharmaceutical Science Communications, 4, 117–124.
   Google Scholar
• BUENING, M. K., and FRANKLIN, M. R., 1976, SKF 525-A inhibition, induction and 452nm complex formation. Drug Metabolism and Disposition, 4, 244–255.
   PubMed Web of Science ®Google Scholar
• El.-GHOMARI, K., and GORROD, J. W., 1987, Metabolic A7-oxygenation of 2,4-diamino-6-substituted pyrimidines. European Journal of Drug Metabolism and Pharmacokinetics, 12, 253–258.
   PubMedGoogle Scholar
• ERNSTER, L., and ORREXIL'S, S., 1965, Substrate-induced synthesis of the hydroxylating enzyme system of liver microsomes. Federal Proceedings, 24, 1190–1199.
   Google Scholar
• ESTABROOK, R. W., FRANKLIN, M. R., and HILDEI3RANDT, A. G, 1970, Factors influencing the inhibitory effect of carbon monoxide on cytochrome P450 catalysed mixed function oxidation reactions. Annals of the New York Academy of Sciences, 174, 218–232.
   Google Scholar
• GoRROD, J.W., 1972, The biological oxidation of aromatic heterocyclic amines. In Biological Oxidation of Nitrogen in Organic Aiolecules, edited by J. W. Bridges, J. W. Gorrod and D. V. Parke (London: Taylor & Francis), pp. 37–47.
   Google Scholar
• GORROD, J. W., 1978, On the multiplicity of iV-oxidase systems. In Developments in Biochemistry, vol. 1. Mechanism of oxidising enzymes, edited by T. P. Singer and R. N. Ondarzo (New York: North-Holland/Elsevier), pp. 189–197.
   Google Scholar
• GoRROD, J. W., and DAMAXI, L. A., 1979a, Some factors involved in the A7-oxidation of 3-substituted pyridines by microsomal preparations in vitro. Xenobiotica, 9, 209–218.
   PubMed Web of Science ®Google Scholar
• GORROD, J. W., and DAMAXI, L. A., 1979b, The effect of various potential inhibitors, activators and inducers on the AT-oxidation of 3-substituted pyridines in vitro. Xenobiotica, 9, 219–226.
   PubMed Web of Science ®Google Scholar
• GORROD, J. W., and PATTERSON, L. H., 1983, The metabolism of 4-substituted A7-ethy1-AT-methylani-lines. III. Effect of various potential inhibitors, activators and inducers on y.-C- and AT-oxidation. Xenobiotica, 13, 521–529.
   PubMed Web of Science ®Google Scholar
• GORROD, J. W., TEMPLE, D. J., and BECKETT, A. H., 1979, The N- and a-C-oxidation of A'1V-dialkylanilines by rabbit liver microsomes in vitro. Xenobiotica, 9, 17–25.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1987, Cytochrome P450 enzymes and drug metabolism. In Progress in Drug Metabolism, edited by J. W. Bridges, L. F. Chasseaud and G. G. Gibson (London: Taylor & Francis), pp. 1–54.
   Google Scholar
• JAPANGE, A. C, DAVIES, S., PRICE, R. J., and LAKE, B. G., 1993, Effect of pretreatment with pyrazine and some derivatives on cytochrome P450 and some enzyme activities in rat liver. Xenobiotica, 23, 169–179.
   PubMedGoogle Scholar
• KADLUBAR, F. F., MILLER, J. A., and MILLER, E. C, 1976, Microsomal K-oxidation of the hepatocarcinogen .V-methyl-4-aminoazobenzene and the reactivity of Ar-hydroxy-A'-methy1-4-aminoazobenzene. Cancer Research, 36, 1196–1206.
   PubMed Web of Science ®Google Scholar
• KAUL, K. L., and NOVAK, R. F., 1987, Inhibition and induction of rabbit liver microsomal cytochrome P450 by pyridine. Journal of Pharmacology and Experimental Therapeutics, 243, 384–390.
   PubMed Web of Science ®Google Scholar
• KIM, S. G., BROOKS, S. C, SALINAS, F., NOVAK,]. C, and NOVAK, R F., 1991, Cytochrome P45011EI induction by thiazole, pyrazine and pyridazine: expression and regulation. Toxicologist, 11, 302.
   Google Scholar
• KIM, S. G., BROOKS, S. C, WAXI;, C, and NOVAK, R. F., 1992, Differential effects of pyridine (PY), thiazole (TH) and pyrazine (PZ) administration on protein expression in rat hepatic and renal microsomes. Toxicologist, 12, 139.
   Google Scholar
• KIM, S. G., WILLIAMS, D. E., SCHLKTA, E. G., GUZELIAN, P. S., and NOVAK, R F., 1988, Pyridine induction of cytochrome P450 in the rat: Role of P450j (alcohol-inducible form) in pyridine iV-oxidation. Journal of Pharmacology and Experimental Therafeutics, 246, 1175–1182.
   PubMed Web of Science ®Google Scholar
• LAM, S. P., 1989, Influence of 9-substitution on the microsomal A -oxidation of adenine. PhD thesis, University of London.
   Google Scholar
• LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MULLER R., and STIKR, A., 1982, Modification of liver microsomal lipids by halothane metabolites; a multi nuclear NMR spectroscopic study. Naunyn-Schmeideberg's Arch Pharmacol, 321, 234–237.
   PubMed Web of Science ®Google Scholar
• NAKAGAWA, M., and ANDO, M., 1977, Metabolism of Credazine, 3-(2'-methylphenoxy) pyridazine, in rats. Agricultural Biological Chemistry, 41, 1975–1984.
   Google Scholar
• NETTER, K. J., 1982, Inhibition of oxidative drug metabolism in microsomes. Pharmacology and Therapeutics, 10, 515–535.
   Google Scholar
• NETTER;ITER, K. J., 1987, Mechanisms of monoxygenase induction and inhibition, Pharmacology and Therapeutics, 33, 1–9.
   Google Scholar
• NOVAK, R. F., KAIL, K. L., and KIM, S. G., 1989, Induction of the alcohol-inducible form of cytochrome P450 by nitrogen containing heterocycles: effects on pyridine iV-oxide production. Drug Metabolism Reviews, 20, 781–792.
   PubMed Web of Science ®Google Scholar
• OMURA and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMedGoogle Scholar
• POULSEN L. L., and ZJECiLKR, D. M., 1979, The liver microsomal FAD-containing monooxygenase. Journal of Biological Chemistry, 254, 6449–6455.
   PubMed Web of Science ®Google Scholar
• SCHENKMAN, J. B., and CINTI, D. L., 1978, Preparation of microsomes with calcium. In Methods of Enzymology, vol. 52, edited by S. Fleischer and L. Packer (New York: Academic), pp. 83–89.
   Google Scholar
• SKELLERN, G. G., and STEER, S. T., 1981, The metabolism of [2-14C]methimazole in the rat. Xenobiotica, 11, 627–634.
   PubMed Web of Science ®Google Scholar
• STIER., A., FINCH, S. A. E., GREINERT, R., HOHNE, M., and MULLK R., 1982, Membrane structure and function of the hepatic microsomal cytochrome P450 system. In Liver and Aging, edited by K, Kitani (London: Elsevier Biomedical Press), pp. 3–14.
   Google Scholar
• TEMPLE, D. J., 1972, The hepatic microsomal metabolism of JV-alkylanilines and related compounds. PhD thesis. University of London.
   Google Scholar
• UEHLEKK, H., 1971, Af-Hydroxylation, Xenobiotica, 1, 327–338.
   PubMedGoogle Scholar
• WATKINS, P. J., and GORROD, J. \V., 1987, Studies on the in vitro biological AT-oxidation of trimethoprim. European Journal of Drug Metabolism and Phannacokinetics, 12, 245–251.
   Google Scholar
• ZIKGLER, D. M., MITCHELL, C, H., and JOLLOW, D., 1969, The properties of a purified hepatic microsomal mixed function amine oxidase. In Microsomes and Drug Oxidations, edited by J. R. Gillette, A. H., Conney, G. I. Cosmides, R. W. Estabrook, J. R. Fouts and G. J. Mannering (New York: Academic), pp. 173–188.
   Google Scholar
• ZIEGLER, D. M., Poi'LSEN", L. L., and MCKEE, E. M., 1971, Interaction of primary amines with a mixed-function amine oxidase isolated from pig liver microsomes. Xenobiotica, 1, 523–531.
   Google Scholar